INTERNATIONAL PATENT: AKSTON BIOSCIENCES CORPORATION FILES APPLICATION FOR "PD-L1 ANALOG FUSION PROTEINS FOR ANTIGEN SPECIFIC IMMUNOTHERAPY AND METHODS OF USE"

GENEVA, Sept. 30 -- AKSTON BIOSCIENCES CORPORATION (100 Cummings Center, Ste 454CBeverly, MA 01915) filed a patent application (PCT/US2025/018549) for "PD-L1 ANALOG FUSION PROTEINS FOR ANTIGEN SPECIFIC IMMUNOTHERAPY AND METHODS OF USE" on Mar 05, 2025. With publication no. WO/2025/198855, the details related to the patent application was published on Sep 25, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ZION, Todd, C. (16 Winter StreetSalem, MA 01970), LANCASTER, Thomas, M. (166 Larch RowWenham, MA 01984)

Abstract: The present disclosure provides recombinantly manufactured fusion proteins...